AGP Picks
View all

American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on June 17, 2026

Linkers Industries Limited Announces Entry into a Material Definitive Agreement
Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212
SemiCab to Showcase Apex Platform at Reuters Events: Supply Chain USA 2026 as a Gold Sponsor
PAYO Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Payoneer Global to Nuvei
Big Digital Energy, Inc. Regains Compliance with Nasdaq Listing Rule 5550(b)(1)
Netskope Enables MSPs to Generate Revenue Faster with Launch of New Catalyst MSP/SP Program and Netskope Partner Orchestrator
WeShop Appoints Maria Weaver as Chief Executive Officer to Lead U.S. Expansion of World's First Community-Owned Shopping Platform
ibex Names Shannon Hodges Senior Vice President of Wave iX
Applied Atomics Secures Exclusive Land-Based License for mPower™ Small Modular Reactor Technology from BWX Technologies
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
Reckoner Launches Reckoner Capital Company, a Finance Company Providing Capital for Risk Retention in Securitizations
Kartoon Studios Secures Approximately $78.5 Million in Litigation Settlements, Transforming Its Balance Sheet
Wearable Devices Ltd. Announces 1-for-3 Reverse Stock Split
Upwork Connects to Claude to Help Businesses Find Expert Human Talent to Turn Ideas into Outcomes
LPL Financial Welcomes Daniel Zacharias to Decorum Wealth Management
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs
IBN Marks Its 20th Anniversary with a Reflection on 2 Decades of Growth, Innovation and the Road Ahead as IBN.Ai
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

American Financial Tribune

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.